Pharmaceutical firm Laurus Labs will hit the capital market this week to raise an estimated Rs 1,332 crore through its initial public offering (IPO).
The IPO is scheduled to open on December 6 and close on December 8.
The offer comprises fresh issue of shares worth Rs 300 crore and an offer for sale of 24,107,440 shares by shareholders -- Aptuit (Asia), Bluewater Investment, FIL Capital Management (Mauritius) and Fidelity India Principals.
The price band for the issue has been set at Rs 426-428 per share. At the upper band, the shares offered by the selling shareholders will fetch Rs 1,332 crore.
The Hyderabad-based company plans to utilise the net proceeds from the fresh issue towards pre-payment of term loans and general corporate purposes.
Kotak Mahindra Capital Company Ltd, Citigroup Global Markets India Private Ltd, Jefferies India Private Ltd and SBI Capital Markets Ltd are the book running lead managers to the offer.
The shares of the company are proposed to be listed on BSE and NSE.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Laurus Labs set for stock trading debut from December 19
Laurus Labs IPO fully subscribed 
Is Laurus Lab IPO a good deal for investors?